Clinical Impact of Breast Cancer Stem Cells in Metastatic Breast Cancer Patients

Table 1

Demographic data of the studied cases.

Age (years)	Median	45.5
	Range	31─70
	Median	50
Family history	Positive family history	3 (4%)
	No family history	73 (96%)
Menopausal status	Premenopausal	33 (43.4%)
	Postmenopausal	43 (56.6%)
Metastatic site	Bone only	10 (13.2%)
	Visceral only	19 (25%)
	Bone and visceral	47 (61.8%)
BCSC expression	BCSC (CD44+ve and CD24−e) 32 patients (42.1%)	Non-BCSC 44 patients (57.9%)